Fibromyalgia and Circadian Blood Pressure

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

July 30, 2021

Conditions
Blood Pressure
Interventions
DEVICE

PBM TREATMENT

Participants randomized to this treatment will receive a whole body PBM treatment using a NovoTHOR® whole body light bed. For each treatment session, participants will lie supine in the treatment bed for 20 minutes, with no or minimal attire (underwear). Treatment sessions will be three times weekly for a period of 4 weeks, totalling 12 treatment sessions

DEVICE

PLACEBO PBM

The placebo feature of the whole body PBM bed provides controls that select active or placebo (sham) treatments in a way undetectable by participant, operator or observers, such that no-one is aware whether the participant is receiving an active or placebo treatment. There is a switch box that randomises participants to active or placebo; no other randomisation is necessary.

Trial Locations (1)

Unknown

Ana González Muñon, Málaga

All Listed Sponsors
lead

University of Malaga

OTHER

NCT05113589 - Fibromyalgia and Circadian Blood Pressure | Biotech Hunter | Biotech Hunter